Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.

JAMA network open - 3 Aug 2020

Zhang Lei, Han Xiaohong, Shi Yuankai

Abstract excerpt

Importance: As the third most frequently mutated gene in cancers, the association between MUC16 mutation and response to immune checkpoint inhibitors (ICIs) in solid tumors remains unclear. Objective: To examine whether MUC16 mutation is associated with genomic factors in ICI response in solid tumors and with outcomes in ICI-treated patients. Design, Setting, and Participants: This cohort study used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to CA-125 Antigen
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Immune Checkpoint Inhibitors

Share to Membrane Proteins

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32845327
DOI: 10.1001/jamanetworkopen.2020.13201
PMCID: PMC7450349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.PMID 32845327Read ↗

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants.Semantic proximity Read ↗

The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.Semantic proximity Read ↗

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.Semantic proximity Read ↗

High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations.Semantic proximity Read ↗

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma.Semantic proximity Read ↗

Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.Semantic proximity Read ↗

MUC16 mutations improve patients’ prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironmentSemantic proximity Read ↗

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancerSemantic proximity Read ↗

MUC4 mutation correlates with tumor mutation burden and the immune microenvironment in colorectal cancerSemantic proximity Read ↗

Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.Semantic proximity Read ↗

Prognostic Biomarker MUC4 Mutations in Colon Adenocarcinoma Correlating with Tumor MicroenvironmentSemantic proximity Read ↗

Characterizing and Forecasting Neoantigens Resulting from MUC Mutations in COADSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.